FDAnews
www.fdanews.com/articles/82174-la-jolla-pharmaceutical-company-reports-third-quarter-and-year-to-date-2005-financial-results

LA JOLLA PHARMACEUTICAL COMPANY REPORTS THIRD QUARTER AND YEAR-TO-DATE 2005 FINANCIAL RESULTS

November 3, 2005

La Jolla Pharmaceutical Company (Nasdaq: LJPC) reported a net loss for the third quarter ended September 30, 2005 of $5.9 million, or $0.08 per share (on 74.0 million weighted average shares), compared to a net loss of $12.8 million, or $0.21 per share (on 61.3 million weighted average shares), for the third quarter of 2004. The net loss for the nine months ended September 30, 2005 was $21.3 million, or $0.29 per share (on 72.5 million weighted average shares), compared to a net loss of $29.6 million, or $0.50 per share (on 59.1 million weighted average shares), for the same period in 2004.

PRNewswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/11-03-2005/0004207355&EDATE=)